Virtu KCG Holdings’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-4,100
Closed -$320K 3575
2015
Q1
$320K Buy
+4,100
New +$311K 0.01% 1838
2014
Q4
Sell
-13,100
Closed -$812K 4037
2014
Q3
$812K Buy
13,100
+3,000
+30% +$191K 0.02% 1158
2014
Q2
$644K Buy
10,100
+3,600
+55% +$219K 0.01% 1661
2014
Q1
$400K Sell
6,500
-15,700
-71% -$915K 0.01% 2213
2013
Q4
$1.27M Sell
22,200
-3,500
-14% -$198K 0.01% 989
2013
Q3
$1.37M Buy
+25,700
New +$1.38M 0.02% 894

Other funds holding MDT

Virtu KCG Holdings's MDT Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Medtronic (MDT) stake by 66% in Q2 2017, selling an estimated $2.36M and leaving 14,238 shares worth $1.26M. The position accounts for 0.04% of the portfolio, ranked #451.

Virtu KCG Holdings first reported a position in MDT in Q3 2013 and has held it in 16 quarters since. The position peaked at $8.3M in Q4 2016. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Virtu KCG Holdings held 14,238 shares of Medtronic worth $1.26M as of Q2 2017.
  • Virtu KCG Holdings sold 28,000 Medtronic shares in Q2 2017, an estimated $2.36M.
  • Medtronic made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #451 holding.
  • Virtu KCG Holdings first reported a position in Medtronic in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Medtronic position peaked at $8.3M in Q4 2016.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.